Want to learn more?
Epi Database provides data from 2005 to 2050 and is segmented by country, indication, year, gender, race and age. All data are thoroughly researched, utilise scientific literature and public and private data sources, and are fully documented to ensure complete transparency.
Trusted for major product decisions
Access reliable epidemiology to accelerate drug discovery, licensing decisions, new indication strategies, and more.
Broad disease coverage
Epi Database covers 1000+ indications and sub indications, including many rare diseases.
Saves time and resources associated with custom study
Robust patient estimates are projected forward and readily available through a user friendly, web-based platform.